fem-1 homolog A pseudogene 3 (FEM1AP3)

fem-1 homolog A pseudogene 3 (FEM1AP3) is annotated as a **pseudogene** in the human genome, specifically located at chromosome 6:112365704-112367444 (hg38)[1]. Pseudogenes are sequences similar to known genes but are generally considered non-functional; they do not produce functional proteins and thus are not considered actionable therapeutic targets. There is no literature describing FEM1AP3 as an active molecular target, disease-relevant gene, or pharmacological protein in humans[1]. The related gene FEM1A (Fem-1 homolog A) encodes a protein involved in ubiquitin-mediated protein degradation and inflammation regulation, but FEM1AP3 itself is a non-coding pseudogene[3][4]. No disease associations, biological functions, or drug interactions are reported for this specific pseudogene. There are no known aliases, functional properties, or established roles of FEM1AP3 in disease or therapy. The full-length, protein-coding version FEM1A (which is different from FEM1AP3) participates in diverse cellular processes[4]. However, FEM1AP3 does not code for a protein. No drugs, biomarkers, or safety information is available because this locus does not encode a therapeutic or molecularly relevant gene product. FEM1AP3 is *not* a therapeutic or molecular target, but simply a pseudogene[1]. The only nomenclature and location data are available; there is no evidence it has a biological activity or relevance in disease. FEM1AP3 is a **pseudogene**, not a functional molecular target, and should not be used as a canonical entry for therapeutic or pharmacological targeting. All relevant structured data fields are null or not applicable except for its official name, abbreviation, and classification as a pseudogene.